MCF Advisors’s 9 Meters Biopharma NMTR Stock Holding History

MCF Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-275	Closed	-$185	–	959
2023 Q2	$185	Hold	275	–	–	﹤0.01%	845
2023 Q1	$383	Hold	275	–	–	﹤0.01%	824
2022 Q4	$346	Hold	275	–	–	﹤0.01%	800
2022 Q3	$1K	Hold	275	–	–	﹤0.01%	803
2022 Q2	$1K	Hold	275	–	–	﹤0.01%	760
2022 Q1	$3K	Buy	+275	New	+$3.75K	﹤0.01%	624
2021 Q4	–	Sell	-275	Closed	-$7K	–	743
2021 Q3	$7K	Hold	275	–	–	﹤0.01%	500
2021 Q2	$6K	Hold	275	–	–	﹤0.01%	489
2021 Q1	$6K	Buy	+275	New	+$8.45K	﹤0.01%	456

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SIS

Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

RFA

MCF Advisors's NMTR Position: Q3 2023 in Review

MCF Advisors sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 275 shares — an estimated $185 sold.

MCF Advisors first reported a position in NMTR in Q1 2021 and held it in 9 quarters. The position peaked at $7K in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

MCF Advisors reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
MCF Advisors sold 275 9 Meters Biopharma shares in Q3 2023, an estimated $185.
MCF Advisors first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 9 quarters.
MCF Advisors's 9 Meters Biopharma position peaked at $7K in Q3 2021.
6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on MCF Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.